NY-ESO Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of NY-ESO Antibodies for the detection and analysis of NY-ESO-1 protein. NY-ESO Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NY-ESO-1 is a cancer/testis antigen expressed in various tumors and is associated with immune responses in cancer patients. Expression is typically restricted to germ cells in the testis, making NY-ESO-1 a significant marker for tumor immunology and a potential target for cancer immunotherapy. Understanding NY-ESO-1 function and regulation provides insights into tumor development and progression mechanisms. NY-ESO-1 research continues to reveal new possibilities in cancer detection and treatment strategies. Investigating NY-ESO-1 expression patterns helps identify potential therapeutic approaches for different cancer types. The role of NY-ESO-1 in immune system responses makes it particularly relevant for immunotherapy development. Santa Cruz Biotechnology monoclonal antibodies for NY-ESO-1 support researchers worldwide in advancing cancer research and developing innovative therapeutic strategies.